Vendredi, 30 Octobre 2020
Dernières nouvelles
Principale » NJ sues drug company amid opioid crisis

NJ sues drug company amid opioid crisis

31 Octobre 2017

NorthJersey.com reported that New Jersey attorney general Christopher Porrino filed a lawsuit against Purdue Pharma, who produces OxyContin. "We allege that Purdue Pharma was chief among these opportunistic and predatory companies".

Prescription opioids have always been linked to the rise in heroin abuse. "Today, my office took the first step toward holding them legally and financially responsible for their deception". "As a company grounded in science, we must balance patient access to FDA-approved medicines, while working collaboratively to solve this public health challenge", the company statement said.

Purdue officials cited in their statement their company's partnership with law enforcement agencies to provide access to the overdose-reversing medication naloxone and the firm's distribution of federal guidelines for prescribing opioids for chronic pain as key initiatives to combat the opioid crisis.

The complaint charges that Purdue manipulated the public and even the medical community to embrace the view that pain was undertreated and that opioids should be the first-line solution for patients suffering from chronic conditions such as moderate back pain, migraine headaches and arthritis.

The lawsuit seeks monetary damages for "false claims, maximum statutory penalties under the Consumer Fraud Act and the False Claims Act, disgorgement of ill-gotten gains and other relief as contribution for the expensive solutions - including addiction treatment and prescriber education - which are necessary to abate the crisis in New Jersey". It also alleges Purdue failed to disclose that it had no studies to support the efficacy or safety of opioid medications for treatment periods longer than 12 weeks.

Shopify Turns A First-Ever Profit In Q3 As Revenue Surges
Revenue was $171.5 million, above expectations for sales of $166.4 million, according to Thomson Reuters I/B/E/S. The average estimate of 16 analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.

It happened because certain companies within the pharmaceutical industry saw a chance to grow their profits by peddling extraordinarily potent, highly-addictive opioid drugs for routine pain.

Other drugmakers also face lawsuits by state and local governments over an opioid epidemic that President Donald Trump last Thursday called a national public health emergency.

The U.S. Centers for Disease Control and Prevention found that, in 2015, drug overdoses killed more than 52,000 Americans.

Last Wednesday, Purdue said it was cooperating with a U.S. Department of Justice probe related to OxyContin. Most involved prescription opioids such as OxyContin or Vicodin or related illicit drugs such as heroin and fentanyl.

NJ sues drug company amid opioid crisis